@article{10591,
  keywords = {Administration, Inhalation, Adrenal Cortex Hormones, Adrenergic beta-2 Receptor Agonists, Bronchodilator Agents, Chlorobenzenes, Cross-Sectional Studies, Drug Combinations, Humans, Muscarinic Antagonists, Nebulizers and Vaporizers, Primary health care, *Pulmonary Disease, Chronic Obstructive/diagnosis/drug therapy, Quinuclidines/adverse effects, chronic obstructive pulmonary disease, multiple-inhaler triple therapy, patient characteristics, single-inhaler triple therapy, triple therapy},
  author = {K. Rothnie and S. Joksaite and L. Sansbury and C. Compton and V. Di Boscio and A. Ismaila},
  title = {Characteristics of New Users of Single- and Multiple-Inhaler Triple Therapy for COPD in Primary Care in England},
  year = {2022},
  journal = {Int J Chron Obstruct Pulmon Dis},
  volume = {17},
  edition = {2022/07/01},
  pages = {1455-1466},
  isbn = {1176-9106 (Print)1176-9106},
  doi = {10.2147/copd.s338436},
  note = {1178-2005
Rothnie, Kieran J
Joksaite, Sandra
Sansbury, Leah B
Compton, Chris
Di Boscio, Valentina
Ismaila, Afisi S
Orcid: 0000-0002-2876-8308
Journal Article
Observational Study
Int J Chron Obstruct Pulmon Dis. 2022 Jun 22;17:1455-1466. doi: 10.2147/COPD.S338436. eCollection 2022.},
  language = {eng},
}